May 21, 2020
Insomnia Data 2020: US Leads in Global Insomnia Clinical Trials, Germany Leads Major European Markets and Japan Has Top Spot in Asia
Mar 31, 2020
2020 Zolpidem Market Study: Worldwide Trends & Developments, Major Players, Patents, and More
Mar 11, 2020
Market of Tert-Butyl Alcohol in Russia: Research & Forecast to 2024 - ResearchAndMarkets.com
Dec 23, 2019
Advisory - One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age
Dec 23, 2019
U.S. FDA Approves Eisai's DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia in Adult Patients
Nov 19, 2019
2019 Tert-butanol Market Study - Global Industry Analysis, Size, Share, Growth, Trends & Forecast to 2027 - ResearchAndMarkets.com
Nov 01, 2019
India Iso Butanol Comprehensive Techno-Commercial Market Study, 2013-2030 - ResearchAndMarkets.com
Sep 27, 2019
Three New Analyses of Data Expand Understanding of the Potential Role for Investigational Agent Lemborexant in Insomnia and Irregular Sleep-Wake Rhythm Disorder
Sep 19, 2019
Eisai to Present New 12-month Safety & Effectiveness Data from Phase 3 Lemborexant SUNRISE 2 Study and New Patient and Cohabitant Insights about Insomnia and Toll on Next-Day Functioning at World Sleep Congress
Jun 11, 2019
Extensive Analyses of Phase 3 Data for Investigational Lemborexant Assess Efficacy and Safety Profile for the Potential Treatment of Insomnia in Adults
May 28, 2019
Eisai to Present Eight Lemborexant Posters at SLEEP 2019 Meeting, Including New Pooled Analyses From Phase 3 Studies and New Phase 1 Data
May 28, 2019
Armas and Micro Labs Announce Collaboration To Launch Generic Injectables to U.S. Market
May 06, 2019
The propanol market size is estimated to be USD 3.5 billion in 2018 and is projected to reach USD 4.2 billion by 2023, at a CAGR of 4.0%
Apr 30, 2019
Eisai and Purdue Pharma Announce Buy Out of Purdue's Rights in Worldwide Collaboration to Develop and Commercialize Lemborexant
Mar 11, 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Mar 06, 2019
Okayama University Research: Inflammation in the Brain Enhances the Side-effects of Hypnotic Medication
Feb 25, 2019
Worldwide Oxo-Alcohol Market Analysis & Outlook, 2019 to 2024 - The Growing Manufacturing Sector is Positively Influencing Global Demand - ResearchAndMarkets.com
Jan 15, 2019
New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
Oct 17, 2018
Eisai and Purdue Pharma Announce Positive Topline Results of SUNRISE 2, the Second Phase 3 Pivotal Study of Lemborexant
Sep 27, 2018
Isobutanol - Global Market Analysis & Forecasts (2018-2025): Emerging Growth Opportunities - ResearchAndMarkets.com